| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.761 | 31.292 | 53.612 | 54.047 | 75.550 | 71.170 | 82.227 | 77.976 | 91.737 |
| Total Income - EUR | - | 11.188 | 32.758 | 53.614 | 54.068 | 82.005 | 72.392 | 82.229 | 77.978 | 96.765 |
| Total Expenses - EUR | - | 5.399 | 17.896 | 29.649 | 28.519 | 33.570 | 36.314 | 37.495 | 43.316 | 48.668 |
| Gross Profit/Loss - EUR | - | 5.789 | 14.862 | 23.965 | 25.549 | 48.435 | 36.078 | 44.734 | 34.661 | 48.097 |
| Net Profit/Loss - EUR | - | 5.681 | 14.549 | 23.428 | 25.009 | 47.680 | 35.366 | 43.912 | 33.936 | 45.397 |
| Employees | - | 2 | 0 | 0 | 2 | 3 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Heliopolis Medical Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 100 | 16.418 | 17.192 | 12.541 | 8.877 | 5.792 | 3.502 | 37.843 | 28.047 |
| Current Assets | - | 8.598 | 8.895 | 38.734 | 19.306 | 73.830 | 51.839 | 60.328 | 15.540 | 39.202 |
| Inventories | - | 0 | 2.472 | 3.775 | 3.762 | 3.516 | 2.908 | 4.900 | 2.938 | 3.704 |
| Receivables | - | 3.208 | 491 | 4.230 | 631 | 7.715 | 985 | 32.603 | 6.474 | 2.550 |
| Cash | - | 5.390 | 5.932 | 30.729 | 14.913 | 62.599 | 47.947 | 22.825 | 6.128 | 32.947 |
| Shareholders Funds | - | 5.726 | 20.178 | 43.236 | 27.369 | 74.530 | 51.803 | 60.401 | 50.383 | 61.765 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.972 | 5.135 | 12.690 | 4.479 | 8.177 | 5.829 | 3.429 | 3.001 | 5.484 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Heliopolis Medical Solutions S.r.l.